JOHN SCRIVANO: Open Payments
NPI 1235224395 · ESCONDIDO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,749 in 85 payments from 15 companies in 2025. Trend: 2023 $1,766 · 2024 $1,212 · 2025 $1,749
Food & beverage: $1,749
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $426 |
| Novo Nordisk Inc | 28 | $396 |
| Dexcom, Inc. | 4 | $227 |
| PFIZER INC. | 8 | $154 |
| ABBVIE INC. | 3 | $93 |
| Kowa Pharmaceuticals America, Inc. | 5 | $87 |
| Lilly USA, LLC | 4 | $73 |
| GlaxoSmithKline, LLC. | 4 | $70 |
| Intra-Sana Laboratories | 1 | $50 |
| Boston Scientific Corporation | 1 | $48 |
Products named: AIRSUPRA, Rybelsus, DEXCOM G7 GSS (161), ELIQUIS, QULIPTA, ZORYVE, Dexcom G6 Transmitter, Ozempic.
Industry payments across CA — which companies pay providers there.
